Management Of Early Relapsed Follicular Lymphoma Debate Favoring Non-Transplant Options
Follicular lymphoma (FL) is the most common non-Hodgkin lymphoma in the United States and Europe1. The disease is potentially incurable and, treatment options comprise a wide spectrum from local radiotherapy to chemoimmunotherapy, based on the risk factors. The outcome of follicular lymphoma patient...
Main Author: | Murat Özbalak |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-10-01
|
Series: | Hematology, Transfusion and Cell Therapy |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2531137923001773 |
Similar Items
-
The role of tazemetostat in relapsed/refractory follicular lymphoma
by: Gottfried von Keudell, et al.
Published: (2021-05-01) -
Modern approaches to the treatment of relapsed follicular lymphoma
by: Yu. E. Ryabukhina, et al.
Published: (2022-07-01) -
Follicular lymphoma transforming to DLBCL and reverting back to follicular lymphoma at relapse—a case report
by: M. C. Suresh Babu, et al.
Published: (2020-05-01) -
Treatment selection for patients with relapsed or refractory follicular lymphoma
by: Alan Z. Skarbnik, et al.
Published: (2023-03-01) -
Relapse of follicular lymphoma arising from a non‐t(14;18) clone
by: Yasuyuki Otsuka, et al.
Published: (2020-07-01)